Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: Systematic review and cost-effectiveness model

Health Technology Assessment

Volumn 17, Issue 53, 2013, Pages

  Sutcliffe, P ^a   Connock, M ^a   Pulikottil Jacob, R ^a   Kandala, N B ^a   Suri, G ^a   Gurung, T ^a   Grove, A ^a   Shyangdan, D ^a   Briscoe, S ^a   Maheswaran, H ^a   Clarke, A ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL DISEASE; ADVERSE OUTCOME; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLEEDING; BODY MASS; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEVICE INFECTION; DIABETES MELLITUS; FUNCTIONAL STATUS; GENDER; HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; ISCHEMIA; KIDNEY FAILURE; LEFT VENTRICULAR ASSIST DEVICE; MALNUTRITION; MULTIPLE ORGAN FAILURE; QUALITY OF LIFE; RACE; REOPERATION; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; THROMBOEMBOLISM; VISUAL ANALOG SCALE; AGE; ECONOMICS; HEART ASSIST DEVICE; MORTALITY; NATIONAL HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; REVIEW; STATISTICAL MODEL; UNITED KINGDOM;

CARDIOTONIC AGENT;

AGE FACTORS; CARDIOTONIC AGENTS; COST-BENEFIT ANALYSIS; GREAT BRITAIN; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MODELS, ECONOMIC; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; STATE MEDICINE; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84888627971     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta17530     Document Type: Article

References (124)

1. MacGowan G, Schueler S, Parry G. The decline in heart transplantation in the UK. BMJ 2011;342: d28483. http://dx.doi.org/10.1136/bmj.d2483
2. Davis RC, Hobbs FD, Lip GY. ABC of heart failure. History and epidemiology. BMJ 2000; 320:39-42. http://dx.doi.org/10.1136/bmj.320.7226.39
3. Poole-Wilson PA. Chronic heart failure: cause, pathophysiology prognosis, clinical manifestations, investigations. In Julian DG, Camm AJ, Fox KF, Hall RJC, editors. Diseases of the Heart. London: Bailliere Tindall; 1989. pp. 24-36.
4. Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, et al. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation. Health Technol Assess 2005;9(45).
5. National Institute for Health and Care Excellence. Chronic heart failure: management of chronic heart failure in adults in primary and secondary care: clinical guideline no. 108. 2010. URL: www.nice.org.uk/nicemedia/live/13099/50517/50517.pdf (accessed 24 May 2012).
6. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Eur J Heart Fail 2008;10:933-89. http://dx.doi.org/10.1016/j. ejheart.2008.08.005
7. British Heart Foundation Health Promotion Research Group. Coronary heart disease statistics: 2010 edition. 2010. URL: www.bhf.org.uk/research/statistics.aspx (accessed 24 May 2012).
8. McMurray JJV, Stewart S. The burden of heart failure. Eur Heart J Suppl 2002;4:D50-D58. http://dx.doi.org/10.1016/S1520-765X(02)90160-4
9. Parameshwar J, Shackell MM, Richardson A, Poole-Wilson PA, Sutton GC. Prevalence of heart failure in three general practices in north west London. Br J Gen Pract 1992;42:287-9.
10. Cowie MR, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Suresh V, et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J 1999;20:421-8. http://dx.doi.org/10.1053/euhj.1998.1280
11. Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 2002;4:361-71. http://dx.doi.org/10.1016/S1388-9842(01)00198-2
12. Petersen S, Rayner M, Wolstenholme J. Coronary heart disease statistics: heart failure supplement. London: British Heart Foundation; 2002.
13. Stewart S, Blue L, Walker A, Morrison C, McMurray JJ. An economic analysis of specialist heart failure nurse management in the UK: can we afford not to implement it? Eur Heart J 2002; 23:1369-78.
14. Fox KF, Cowie MR, Wood DA, Coats AJ, Gibbs JS, Underwood SR, et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001;22:228-36. http://dx.doi.org/10.1053/euhj.2000.2289
15. Palazzuoli A, Nuti R. Heart failure: pathophysiology and clinical picture. Contrib Nephrol 2010;164:1-10. http://dx.doi.org/10.1159/000313714
16. Cohn JN. The management of chronic heart failure. N Engl J Med 1996;335:490-8.
17. McMurray JJV, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000;83:596-602. http://dx.doi.org/10.1136/heart.83.5.596
18. Criteria Committee of the NYHA. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th edn. Boston, MA: Little Brown & Co; 1994. pp. 253-6.
19. Scottish Intercollegiate Guidelines Network. Management of chronic heart failure: a national clinical guideline: no. 95. 2007. URL: www.sign.ac.uk/pdf/sign95.pdf (accessed 24 May 2012).
20. Mant J, Al-Mohammad A, Swain S, Laramee P. Management of chronic heart failure in adults: synopsis of the National Institute For Health and clinical excellence guideline. Ann Intern Med 2011;155:252-9. http://dx.doi.org/10.7326/0003-4819-155-4-201108160-00009
21. Sutherland K. Bridging the quality gap: Heart failure. 2010. URL: www.health.org.uk/publications/ bridging-the-quality-gap-heart-failure/ (accessed 28 May 2012).
22. Murphy NF, Simpson CR, McAlister FA, Stewart S, MacIntyre K, Kirkpatrick M, et al. National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland. Heart 2004;90:1129-36. http://dx.doi.org/10.1136/hrt.2003.029553
23. O'Leary N, Murphy NF, O'Loughlin C, Tiernan E, McDonald K. A comparative study of the palliative care needs of heart failure and cancer patients. Eur J Heart Fail 2009;11:406-12. http://dx.doi.org/10.1093/eurjhf/hfp007
24. de Giuli F, Khaw KT, Cowie MR, Sutton GC, Ferrari R, Poole-Wilson PA. Incidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom. Eur J Heart Fail 2005;7:295-302.
25. Hobbs FD, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 2002;23:1867-76. http://dx.doi.org/10.1053/euhj.2002.3255
26. Bartoli CR, Dowling RD. The future of adult cardiac assist devices: novel systems and mechanical circulatory support strategies. Cardiol Clin 2011;29:559-82. http://dx.doi.org/10.1016/ j.ccl.2011.08.013
27. Friedrich EB, Bohm M. Management of end stage heart failure. Heart 2007;93:626-31. http://dx.doi.org/10.1136/hrt.2006.098814
28. Banner NR, Bonser RS, Clark AL, Clark S, Cowburn PJ, Gardner RS, et al. UK guidelines for referral and assessment of adults for heart transplantation. Heart 2011;97:1520-7. http://dx.doi.org/10.1136/heartjnl-2011-300048
29. Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report-2010. J Heart Lung Transplant 2010;29:1089-103. http://dx.doi.org/10.1016/ j.healun.2010.08.007
30. Sharples LD, Buxton M, Caine N, Cafferty F, Demiris N, Dyer M, et al. Evaluation of the ventricular assist device programme in the UK. Health Technol Assess 2006;10(48). http://dx.doi.org/ 10.1016/j.healun.2006.09.011
31. Australian Safety and Efficacy Register of New Interventional Procedures-Surgical (ASERNIP-S). Continuous flow ventricular assist devices for bridge to transplantation. 2008. URL: www.horizonscanning.gov.au/internet/horizon/publishing.nsf/Content/ 211ABF81A69CA39DCA2575AD0080F3DC/$File/HSR%20%20Continuous%20flowVADs% 20HSR%20Nov%2008.pdf (accessed 14 June 2013).
32. Stewart GC, Givertz MM. Mechanical circulatory support for advanced heart failure: patients and technology in evolution. Circulation 2012;125:1304-15. http://dx.doi.org/10.1161/ CIRCULATIONAHA.111.060830
33. Shams OF, Ventura HO. Device therapy for heart failure: when and for whom? Am J Cardiovasc Drugs 2008;8:147-53. http://dx.doi.org/10.2165/00129784-200808030-00001
34. Kirklin JK, Naftel D, Kormos R, Stevenson LW, Pagani FD, Miller MA, et al. Third INTERMACS annual report: the evolution of destination therapy in the United States. J Heart Lung Transplant 2011;302:115-23. http://dx.doi.org/10.1016/j.healun.2010.12.001
35. Birks EJ. Left ventricular assist devices. Heart 2010;96:63-71. http://dx.doi.org/10.1136/ hrt.2007.130740
36. Birks EJ. The comparative use of ventricular assist devices: differences between Europe and the United States. Tex Heart Inst J 2010;37:565-7.
37. Nguyen DQ, Thourani VH. Third-generation continuous flow left ventricular assist devices. Innov Technol Tech Cardiothorac Vasc Surg 2010;5:250-8. http://dx.doi.org/10.1097/ IMI.0b013e3181ee77a1
38. Thoratec. A new era for the treatment of advanced heart failure: 2008 annual report. 2008. URL: http://phx.corporate-ir.net/External.File? item=UGFyZW50SUQ9MzMyMjk4fENoaWxkSUQ9MzE0ODY5fFR5cGU9MQ==&t=1 (accessed 28 May 2012).
39. Noon GP, Loebe M. Current status of the MicroMed DeBakey Noon Ventricular Assist Device. Tex Heart Inst J 2010;37:652-3.
40. Timms D. A review of clinical ventricular assist devices. Med Eng Phys 2011;33:1041-7. http://dx.doi.org/10.1016/j.medengphy.2011.04.010
41. Terumo Heart. How DuraHeart works. 2012. URL: www.terumoheart.com/us/index.php/ medical-professionals/how-it-works (accessed 31 May 2012).
42. Morshuis M, Schoenbrodt M, Nojiri C, Roefe D, Schulte-Eistrup S, Boergermann J, et al. DuraHeart magnetically levitated centrifugal left ventricular assist system for advanced heart failure patients. Expert Rev Med Devices 2010;7:173-83. http://dx.doi.org/10.1586/erd.09.68
43. Krishnamani R, DeNofrio D, Konstam MA. Emerging ventricular assist devices for long-term cardiac support. Nat Rev Cardiol 2010;7:71-6. http://dx.doi.org/10.1038/nrcardio.2009.222
44. Felix SE, Martina JR, Kirkels JH, Klopping C, Nathoe H, Sukkel E, et al. Continuous flow left ventricular assist device support in patients with advanced heart failure: points of interest for the daily management. Eur J Heart Fail 2012;14:351-6. http://dx.doi.org/10.1093/eurjhf/hfs012
45. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345: 1435-43. http://dx.doi.org/10.1056/NEJMoa012175
46. Stevenson LW, Miller LW, Desvigne-Nickens P, Ascheim DD, Parides MK, Renlund DG, et al. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation 2004;110:975-81. http://dx.doi.org/10.1161/01. CIR.0000139862.48167.23
47. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous flow left ventricular assist device. New Engl J Med 2009; 361:2241-51. http://dx.doi.org/10.1056/NEJMoa0909938
48. Potapov EV, Stepanenko A, Krabatsch T, Hetzer R. Managing long-term complications of left ventricular assist device therapy. Curr Opin Cardiol 2011;26:237-44. http://dx.doi.org/10.1097/ HCO.0b013e328345af80
49. Barnes K. Complications in patients with ventricular assist devices. Dimens Critic Care Nurs 2008;27:233-43. http://dx.doi.org/10.1097/01.DCC.0000338867.24293.20
50. Pepper JR. Update on mechanical circulatory support in heart failure. Heart 2012;98:663-9. http://dx.doi.org/10.1136/heartjnl-2011-300735
51. Slaughter MS. UNOS status of heart transplant patients supported with a left ventricular assist device: is it time to reconsider the status criteria? Tex Heart Inst J 2011;38:549-51.
52. Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, et al. Results of the post-U. S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011;57:1890-8.
53. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 2010;55:1826-34. http://dx.doi.org/10.1016/j.jacc.2009.12.052
54. Centre for Reviews and Dissemination. CRD's guidance for undertaking reviews in health care. 2008. URL: www.york.ac.uk/inst/crd/pdf/Systematic_Reviews.pdf (accessed 18 June 2012).
55. Thomas BH, Ciliska D, Dobbins M, Micucci S. A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs 2004;1:176-84. http://dx.doi.org/10.1111/j.1524-475X.2004.04006.x
56. Adamson RM, Stahovich M, Chillcott S, Baradarian S, Chammas J, Jaski B, et al. Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device: a community hospital experience. J Am Coll Cardiol 2011;57:2487-95.
57. Bogaev RC, Pamboukian SV, Moore SA, Chen L, John R, Boyle AJ, et al. Comparison of outcomes in women versus men using a continuous flow left ventricular assist device as a bridge to transplantation. J Heart Lung Transplant 2011;30:515-22. http://dx.doi.org/10.1016/ j.healun.2010.12.009
58. Boyle AJ, Russell SD, Teuteberg JJ, Slaughter MS, Moazami N, Pagani FD, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant 2009;28:881-7. http://dx.doi.org/ 10.1016/j.healun.2009.05.018
59. Brewer RJ, Lanfear DE, Sai-Sudhakar CB, Sundareswaran KS, Ravi Y, Farrar DJ, et al. Extremes of body mass index do not impact mid-term survival after continuous flow left ventricular assist device implantation. J Heart Lung Transplant 2012;31:167-72. http://dx.doi.org/10.1016/ j.healun.2011.11.006
60. Cowger J, Pagani FD, Haft JW, Romano MA, Aaronson KD, Kolias TJ. The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail 2010;3:668-74.
61. Demirozu ZT, Radovancevic R, Hochman LF, Gregoric ID, Letsou GV, Kar B, et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 2011;30:849-53. http://dx.doi.org/10.1016/j.healun.2011.03.008
62. Hasin T, Topilsky Y, Schirger JA, Li Z, Zhao Y, Boilson BA, et al. Changes in renal function after implantation of continuous flow left ventricular assist devices. J Am Coll Cardiol 2012;59:26-36. http://dx.doi.org/10.1016/j.jacc.2011.09.038
63. John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, et al. Post-cardiac transplant survival after support with a continuous flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. J Thorac Cardiovasc Surg 2010;140:174-81. http://dx.doi.org/10.1016/j.jtcvs.2010.03.037
64. John R, Kamdar F, Eckman P, Colvin-Adams M, Boyle A, Shumway S, et al. Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices. Ann Thorac Surg 2011;92:1593-9. http://dx.doi.org/10.1016/j.athoracsur.2011.06.081
65. John R, Naka Y, Smedira NG, Starling R, Jorde U, Eckman P, et al. Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. Ann Thorac Surg 2011;92:1406-13. http://dx.doi.org/10.1016/j.athoracsur.2011.05.080
66. Kato TS, Schulze PC, Yang J, Chan E, Shahzad K, Takayama H, et al. Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. J Heart Lung Transplant 2012;31:1-8. http://dx.doi.org/10.1016/j.healun.2011.08.014
67. Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, et al. Right ventricular failure in patients with the HeartMate II continuous flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010;139:1316-24. http://dx.doi.org/10.1016/j.jtcvs.2009.11.020
68. Lahpor J, Khaghani A, Hetzer R, Pavie A, Friedrich I, Sander K, et al. European results with a continuous flow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg 2010;37:357-61. http://dx.doi.org/10.1016/j.ejcts.2009.05.043
69. Martin SI, Wellington L, Stevenson KB, Mangino JE, Sai-Sudhakar CB, Firstenberg MS, et al. Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days. Interact Cardiovasc Thorac Surg 2010;11:20-3. http://dx.doi.org/10.1510/ icvts.2009.227801
70. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous flow device in patients awaiting heart transplantation. [Reprint in Nat Clin Pract Cardiovasc Med 2008;5(2):80-1.] New Engl J Med 2007;357:885-96. http://dx.doi.org/10.1056/NEJMoa067758
71. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, et al. Extended mechanical circulatory support with a continuous flow rotary left ventricular assist device. J Am Coll Cardiol 2009;54:312-21. http://dx.doi.org/10.1016/j.jacc.2009.03.055
72. Pak S-W, Uriel N, Takayama H, Cappleman S, Song R, Colombo PC, et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transplant 2010;29:1172-6. http://dx.doi.org/10.1016/j.healun.2010.05.018
73. Pal JD, Klodell CT, John R, Pagani FD, Rogers JG, Farrar DJ, et al. Low operative mortality with implantation of a continuous flow left ventricular assist device and impact of concurrent cardiac procedures. Circulation 2009;120(Suppl. 9):S215-19. http://dx.doi.org/10.1161/ CIRCULATIONAHA.108.844274
74. Petrucci RJ, Wright S, Naka Y, Idrissi KA, Russell SD, Dordunoo D, et al. Neurocognitive assessments in advanced heart failure patients receiving continuous flow left ventricular assist devices. J Heart Lung Transplant 2009;28:542-9. http://dx.doi.org/10.1016/j.healun.2009.02.007
75. Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, et al. Renal and hepatic function improve in advanced heart failure patients during continuous flow support with the HeartMate II left ventricular assist device. Circulation 2009;120:2352-7. http://dx.doi.org/ 10.1161/CIRCULATIONAHA.108.814863
76. Schaffer JM, Allen JG, Weiss ES, Arnaoutakis GJ, Patel ND, Russell SD, et al. Infectious complications after pulsatile-flow and continuous flow left ventricular assist device implantation. J Heart Lung Transplant 2011;30:164-74. http://dx.doi.org/10.1016/j.healun.2010.08.003
77. Schaffer JM, Allen JG, Weiss ES, Patel ND, Russell SD, Shah AS, et al. Evaluation of risk indices in continuous flow left ventricular assist device patients. Ann Thorac Surg 2009;88:1889-96. http://dx.doi.org/10.1016/j.athoracsur.2009.08.011
78. Strueber M, Sander K, Lahpor J, Ahn H, Litzler PY, Drakos SG, et al. HeartMate II left ventricular assist device; early European experience. Eur J Cardiothorac Surg 2008;34:289-94. http://dx.doi.org/10.1016/j.ejcts.2008.05.011
79. Topilsky Y, Pereira NL, Shah DK, Boilson B, Schirger JA, Kushwaha SS, et al. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail 2011;4:266-75. http://dx.doi.org/10.1161/CIRCHEARTFAILURE.110.959288
80. Topilsky Y, Hasin T, Oh JK, Borgeson DD, Boilson BA, Schirger JA, et al. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome. Circ Cardiovasc Imaging 2011;4:648-61. http://dx.doi.org/10.1161/CIRCIMAGING.111.965335
81. Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, et al. Acquired von Willebrand syndrome after continuous flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 2010;56:1207-13. http://dx.doi.org/10.1016/j.jacc.2010.05.016
82. Ventura PA, Alharethi R, Budge D, Reid BB, Horne BD, Mason NO, et al. Differential impact on post-transplant outcomes between pulsatile-and continuous flow left ventricular assist devices. Clin Transplant 2011;25:E390-E395. http://dx.doi.org/10.1111/j.1399-0012.2011.01433.x
83. Strueber M, O'Driscoll G, Jansz P, Khaghani A, Levy WC, Wieselthaler GM, et al. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol 2011;57:1375-82. http://dx.doi.org/10.1016/j.jacc.2010.10.040
84. Goldstein DJ. Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation. Circulation 2003;108(Suppl. 9):II272-7. http://dx.doi.org/10.1161/01. cir.0000087387.02218.7e
85. Morshuis M, El-Banayosy A, Arusoglu L, Koerfer R, Hetzer R, Wieselthaler G, et al. European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system. Eur J Cardiothorac Surg 2009;35:1020-7. http://dx.doi.org/10.1016/j.ejcts.2008.12.033
86. Schmid C, Jurmann M, Birnbaum D, Colombo T, Falk V, Feltrin G, et al. Influence of inflow cannula length in axial-flow pumps on neurologic adverse event rate: results from a multicenter analysis. J Heart Lung Transplant 2008;27:253-60. http://dx.doi.org/10.1016/ j.healun.2007.12.007
87. Drews T, Stepanenko A, Dandel M, Buz S, Lehmkuhl HB, Hetzer R. Mechanical circulatory support in patients of advanced age. Eur J Heart Fail 2010;12:990-4. http://dx.doi.org/10.1093/ eurjhf/hfq076
88. Klotz S, Stypmann J, Welp H, Schmid C, Drees G, Rukosujew A, et al. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant? Ann Thorac Surg 2006;82:1774-8. http://dx.doi.org/10.1016/ j.athoracsur.2006.05.079
89. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, et al. Changing outcomes in patients bridged to heart transplantation with continuous-versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2011;30:854-61. http://dx.doi.org/10.1016/ j.healun.2011.03.019
90. Oswald H, Schultz-Wildelau C, Gardiwal A, Lusebrink U, Konig T, Meyer A, et al. Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur J Heart Fail 2010;12:593-9. http://dx.doi.org/10.1093/eurjhf/hfq048
91. Sandner SE, Zimpfer D, Zrunek P, Rajek A, Schima H, Dunkler D, et al. Age and outcome after continuous flow left ventricular assist device implantation as bridge to transplantation. J Heart Lung Transplant 2009;28:367-72. http://dx.doi.org/10.1016/j.healun.2009.01.008
92. Sandner SE, Zimpfer D, Zrunek P, Rajek A, Schima H, Dunkler D, et al. Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg 2009;87:1072-8. http://dx.doi.org/10.1016/j.athoracsur.2009.01.022
93. Duncan BW, Lorenz M, Kopcak MW, Fukamachi K, Ootaki Y, Chen HM, et al. The PediPump: a new ventricular assist device for children. Artif Organs 2005;29:527-30. http://dx.doi.org/ 10.1111/j.1525-1594.2005.29088.x
94. Aaronson KD, Slaughter MS, Miller LW, McGee EC, Cotts WG, Acker MA, et al. Use of an intrapericardial, continuous flow, centrifugal pump in patients awaiting heart transplantation/ clinical perspective. Circulation 2012;125:3191-200.
95. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006;113:1424-33. http://dx.doi. org/10.1161/CIRCULATIONAHA.105.584102
96. Black N, Barker M, Payne M. Cross sectional survey of multicentre clinical databases in the United Kingdom. BMJ 2004;328:1478. http://dx.doi.org/10.1136/bmj.328.7454.1478
97. Drummond A, Bachman T, Antaki J. Three-dimensional virtual anatomic fit study for an implantable pediatric ventricular assist device. Comput Sci 2006;3994:855-61. http://dx.doi.org/ 10.1007/11758549_114
98. Moreno SG, Novielli N, Cooper NJ. Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation. J Heart Lung Transplant 2012;31:450-8. http://dx.doi.org/10.1016/j.healun.2011.10.017
99. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007;116:497-505. http://dx.doi.org/10.1161/ CIRCULATIONAHA.107.691972
100. Russo MJ, Hong KN, Davies RR, Chen JM, Sorabella RA, Ascheim DD, et al. Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices. J Thorac Cardiovasc Surg 2009;138:1425-32. http://dx.doi.org/10.1016/ j.jtcvs.2009.07.034
101. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal. 2008. URL: www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf (accessed 29 May 2012).
102. Rogers WJ, Johnstone DE, Yusuf S, Weiner DH, Gallagher P, Bittner VA, et al. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies Of Left Ventricular Dysfunction. The SOLVD Investigators. J Am Coll Cardiol 1994;23:393-400. http://dx.doi.org/10.1016/0735-1097(94)90426-X
103. Miller K, Myers TJ, Robertson K, Shah N, Delgado RM, III, Gregoric ID. Quality of life in bridge-to-transplant patients with chronic heart failure after implantation of an axial flow ventricular assist device. Congestive Heart Fail 2004;10:226-9. http://dx.doi.org/10.1111/ j.1527-5299.2004.03258.x
104. Kugler C, Malehsa D, Tegtbur U, Guetzlaff E, Meyer AL, Bara C, et al. Health-related quality of life and exercise tolerance in recipients of heart transplants and left ventricular assist devices: a prospective, comparative study. J Heart Lung Transplant 2011;30:204-10. http://dx.doi.org/10.1016/j.healun.2010.08.030
105. Ortega T, Diaz-Molina B, Montoliu MA, Ortega F, Valdes C, Rebollo P, et al. The utility of a specific measure for heart transplant patients: reliability and validity of the Kansas City Cardiomyopathy Questionnaire. Transplantation 2008;86:804-10. http://dx.doi.org/10.1097/ TP.0b013e318183eda4
106. Almenar-Pertejo M, Almenar L, Martinez-Dolz L, Campos J, Galan J, Girones P, et al. Study on health-related quality of life in patients with advanced heart failure before and after transplantation. Transplant Proc 2006;38:2524-6. http://dx.doi.org/10.1016/ j.transproceed.2006.08.017
107. Grady KL, Naftel DC, Kobashigawa J, Chait J, Young JB, Pelegrin D, et al. Patterns and predictors of quality of life at 5 to 10 years after heart transplantation. J Heart Lung Transplant 2007;26:535-43. http://dx.doi.org/10.1016/j.healun.2007.01.042
108. Kugler C, Tegtbur U, Gottlieb J, Bara C, Malehsa D, Dierich M, et al. Health-related quality of life in long-term survivors after heart and lung transplantation: a prospective cohort study. Transplantation 2010;90:451-7. http://dx.doi.org/10.1097/TP.0b013e3181e72863
109. Politi P, Piccinelli M, Poli PF, Klersy C, Campana C, Goggi C, et al. Ten years of 'extended' life: quality of life among heart transplantation survivors. Transplantation 2004;78:257-63. http://dx.doi.org/10.1097/01.TP.0000133537.87951.F2
110. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
111. Gohler A, Geisler BP, Manne JM, Kosiborod M, Zhang Z, Weintraub WS, et al. Utility estimates for decision-analytic modeling in chronic heart failure-health states based on New York Heart Association classes and number of rehospitalizations. Value Health 2009;12:185-7. http://dx.doi.org/10.1111/j.1524-4733.2008.00425.x
112. Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes 2010;8:13. http://dx.doi.org/ 10.1186/1477-7525-8-13
113. Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W, et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002;87:235-41. http://dx.doi.org/10.1136/ heart.87.3.235
114. Office for National Statistics. Topic guide to: mortality rates. 2001. URL: www.statistics.gov.uk/ hub/population/deaths/mortality-rates (accessed 25 June 2012).
115. NICE Decision Support Unit. Technical support documents. 2011. URL: www.nicedsu.org.uk/ Technical-Support-Documents(1985314).htm (accessed 19 June 2012).
116. Slaughter MS, Rogers JG. Editorial commentary: determining the cost-effectiveness of mechanical circulatory support. J Heart Lung Transplant 2012;31:448-9. http://dx.doi.org/10.1016/ j.healun.2012.02.013
117. Collett D. Modelling survival data in medical research. 2nd edn. Boca Raton, FL: CRC Press LLC; 2003.
118. Goldsmith K, Sharples L, Sudarshan C, Parameshwar J, Tsui S, Wallwork J, et al. Twenty-five years of heart transplantation at a single centre: changes in factors influencing short-and long-term survival over time. J Heart Lung Transplant 2007;262:S205. http://dx.doi.org/10.1016/ j.healun.2006.11.426
119. Rose EA, Moskowitz AJ, Packer M, Sollano JA, Williams DL, Tierney AR, et al. The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg 1999;67:723-30. http://dx.doi.org/ 10.1016/S0003-4975(99)00042-9
120. Curtis L. Unit costs of health and social care 2011. Kent: University of Kent; Personal Social Services Research Unit; 2011.
121. Personal Social Services Research Unit. Unit costs of health & social care. 2010. URL: www.education.gov.uk/publications/eOrderingDownload/PSSRU-1368-230X.pdf (accessed 18 June 2012).
122. National schedule of reference costs 2010-11. Appendix NSRC04: NHS Trusts and PTs combined reference cost schedules. London: Department of Health. URL: www.gov.uk/government/ publications/2010-11-reference-costs-publication (accessed 16 November 2012).
123. Girling AJ, Freeman G, Gordon JP, Poole-Wilson P, Scott DA, Lilford RJ. Modeling payback from research into the efficacy of left-ventricular assist devices as destination therapy. Int J Technol Assess Health Care 2007;23:269-77. http://dx.doi.org/10.1017/S0266462307070365
124. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiologic Health. Assessment of neurological/neurocognitive function: guidance for industry and FDFA reviewers. Washington, DC: USDHHS; 2003.